Real-time enrollment status for this systemic amyloidosis clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 6:31 PM UTC
| NCT Number | NCT05951816 |
| Recruiting Status | Recruiting |
| Condition | Systemic Amyloidosis |
| Phase | PHASE1 |
| Target Enrollment | 31 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Tennessee Graduate School of Medicine |
| Last Updated on CT.gov | July 24, 2026 (Jul 24, 2026) |
As of August 31, 2026: Clinical trial NCT05951816 is currently recruiting participants. This phase1 study for systemic amyloidosis is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Tennessee Graduate School of Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05951816 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05951816 was last updated Jul 24, 2026 (July 24, 2026). HelloStudys verifies this status automatically.